USP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cells-Reference-Cited by-同舟云学术

USP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cells

Published:2019-09-11 Issue:15 Volume:8 Page:6730-6740
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lu Qin¹,Zhang Fang‐Lin¹²³,Lu Da‐Yun⁴,Shao Zhi‐Ming¹²³⁵⁶,Li Da-Qiang¹²³⁵⁶^ORCID

Affiliation:

1. Shanghai Cancer Center and Institutes of Biomedical Sciences Shanghai Medical College Fudan University Shanghai China

2. Cancer Institute Shanghai Medical College Fudan University Shanghai China

3. Department of Oncology Shanghai Medical College Fudan University Shanghai China

4. Department of Analytical Chemistry and CAS Key Laboratory of Receptor Research Shanghai Institute of Materia Medica Chinese Academy of Sciences Shanghai China

5. Department of Breast Surgery Shanghai Medical College Fudan University Shanghai China

6. Key Laboratory of Breast Cancer in Shanghai Shanghai Medical College Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Fudan University

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2528

Reference66 articles.

1. Cancer Susceptibility and the Functions of BRCA1 and BRCA2

2. BRCA1 at the crossroad of multiple cellular pathways: approaches for therapeutic interventions

3. BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP

4. Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response

5. CCDC98 is a BRCA1-BRCT domain–binding protein involved in the DNA damage response

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. USP9X/HOXA1 Contributes to the Cisplatin-Resistentance of Oral Squamous Cell Carcinoma in vitro and in vivo;International Journal of Pharmacology;2024-08-01

2. The deubiquitinating enzyme USP4 regulates BRCA1 stability and function;npj Breast Cancer;2024-05-11

3. Cellular functions, molecular signalings and therapeutic applications: Translational potential of deubiquitylating enzyme USP9X as a drug target in cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-05

4. USP15 facilitates the progression of bladder cancer by amplifying the activation of the NF-κB signaling pathway;Aging;2024-03-28

5. Friend or foe? Reciprocal regulation between E3 ubiquitin ligases and deubiquitinases;Biochemical Society Transactions;2024-02-28